Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Date

October 15, 2017

Model-informed biomarker qualification: Alzheimer disease (AD) and Parkinson disease (PD) imaging biomarkers

Conrado, D.J., et al.; “Model-informed biomarker qualification: Alzheimer disease (AD) and Parkinson disease (PD) imaging biomar

October 15, 2017

Data sharing and standardization to expand a patient-level database of a regulatory-endorsed clinical trial simulator for Alzheimer disease (AD)

Burton, J., et al.; “Data sharing and standardization to expand a patient-level database of a regulatory-endorsed clinical trial

October 9, 2017

Critical Path Innovation Meeting

On September 14, 2017, Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium and Electronic Patient-Repor

October 3, 2017

Mobile Devices in Clinical Trials for Neurological Diseases: CDISC Standards Development

March 10, 2017 Pointe Hilton Tapatio Cliffs Resort | Phoenix, AZ Overview and Objectives The Coalition Against Major Diseas

October 1, 2017

Apolipoprotein E genotype and sex risk factors for Alzheimer disease

September 23, 2017

Seeking a Better Landscape for Therapy Development in Neuromuscular Disorders

September 22, 2017

Biometric Monitoring Devices for Objective Assessments of Relevant Endpoints for Clinical Drug Trials: Key Considerations in Developing an Actionable Eco-system

September 11, 2017

C-Path, CHDI Foundation, and CDISC Announce Public Review Period for Huntington’s Disease Therapeutic Area User Guide

September 11, 2017 TUCSON, AZ, NEW YORK, NY, and AUSTIN, TX – September 11, 2017 – Critical Path Institute (C-Pa

August 17, 2017

The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability

August 17, 2017

National MS Society-Supported Collaborators Publish Reviews of Tools Used to Measure MS Progression

Previous8889 90...134 Next